Xie Xinping, Huang Yuxiu, Chen Lihong, Wang Jinhua
Department of Gynecology and Obstetrics, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian 350004, P.R. China.
Oncol Lett. 2018 Nov;16(5):6697-6704. doi: 10.3892/ol.2018.9446. Epub 2018 Sep 18.
To observe the expression of microRNA-221 (miR-221) in ovarian cancer tissues and its effect and associated mechanism on proliferation and apoptosis in the ovarian cancer SKOV3 cell line. The expression of miR-221 and B-cell lymphoma 2 modifying factor (BMF) mRNA in ovarian cancer and para-carcinoma tissues was detected by reverse transcription-quantitative polymerase chain reaction, the expression of BMF was detected by western blot. MicroRNA.org online predicted that BMF was the possible target gene of miR-221, and the regulatory association was validated by a dual-luciferase reporter gene assay. SKOV3 cells were divided into 8 transfection groups: Anti-miR-negative control (NC); anti-miR-221; phosphorylated internal ribosome entry site 2 (pIRES2)-blank, pIRES2-BMF, small interfering (si)-NC, si-BMF, anti-miR-221+si-BMF and anti-miR-221+pIRES2-BMF groups. Cell proliferation was detected by EdU staining flow cytometry. The effect of transfection on cell apoptosis was detected by Annexin V/PI double staining, and the activity of caspase-3 was detected by spectrophotometry. The effect of anti-miR-221 or pIRES2-BMF transfection on SKOV3 cell proliferation was detected by MTT assay and flow cytometry, and the effect on apoptosis was detected by the Annexin V/PI double staining. Compared with para-cancer tissues, the miR-221 expression was significantly upregulated (P<0.001), the BMF mRNA expression was significantly downregulated (P<0.001), and the expression of BMF proteins was significantly downregulated in the ovarian cancer tissues. Dual-luciferase reporter gene assay confirmed a targeted regulatory association between miR-221 and BMF. The anti-miR-221 or pIRES2-BMF transfection significantly upregulated BMF expression in SKOV3 cells, significantly decreased cell proliferation and significantly increased cell apoptosis. The overexpression of BMF may enhance the proapoptotic and proliferation-inhibition effect of anti-miR-221 on SKOV3 cells. The transfection of si-BMF significantly promoted cell proliferation, reduced cell apoptosis and attenuated the proapoptotic and proliferation-inhibition effect of anti-miR-221 on cells. The expression of miR-221 was significantly upregulated and the expression of BMF was significantly down-regulated in ovarian cancer tissues. The overexpression of miR-221 antagonized the apoptosis of ovarian cancer SKOV3 cell and promoted the cell proliferation by targeted inhibition of the expression of BMF, which may serve a role in the pathogenesis of ovarian cancer.
观察微小RNA-221(miR-221)在卵巢癌组织中的表达及其对卵巢癌SKOV3细胞系增殖和凋亡的影响及相关机制。采用逆转录-定量聚合酶链反应检测卵巢癌组织和癌旁组织中miR-221和B细胞淋巴瘤2修饰因子(BMF)mRNA的表达,采用蛋白质免疫印迹法检测BMF的表达。MicroRNA.org在线预测BMF是miR-221的可能靶基因,并通过双荧光素酶报告基因检测验证调控关系。将SKOV3细胞分为8个转染组:抗miR阴性对照(NC)组;抗miR-221组;磷酸化内部核糖体进入位点2(pIRES2)-空白组、pIRES2-BMF组、小干扰(si)-NC组、si-BMF组、抗miR-221+si-BMF组和抗miR-221+pIRES2-BMF组。采用EdU染色流式细胞术检测细胞增殖情况。采用Annexin V/PI双染法检测转染对细胞凋亡的影响,采用分光光度法检测caspase-3的活性。采用MTT法和流式细胞术检测抗miR-221或pIRES2-BMF转染对SKOV3细胞增殖的影响,采用Annexin V/PI双染法检测对细胞凋亡的影响。与癌旁组织相比,卵巢癌组织中miR-221表达显著上调(P<0.001),BMF mRNA表达显著下调(P<0.001),BMF蛋白表达也显著下调。双荧光素酶报告基因检测证实miR-221与BMF之间存在靶向调控关系。抗miR-221或pIRES2-BMF转染可显著上调SKOV3细胞中BMF的表达,显著降低细胞增殖并显著增加细胞凋亡。BMF的过表达可能增强抗miR-221对SKOV3细胞的促凋亡和增殖抑制作用。si-BMF转染显著促进细胞增殖,降低细胞凋亡,并减弱抗miR-221对细胞的促凋亡和增殖抑制作用。卵巢癌组织中miR-221表达显著上调,BMF表达显著下调。miR-